Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from Syncona Shs GBP ( (GB:SYNC) ) is now available.
Syncona Limited announced the purchase of 150,000 of its own ordinary shares as part of its ongoing share buyback programme. These shares will be held in treasury, thereby reducing the total voting rights to 622,297,839. This move is in line with their strategy to manage share capital effectively and deliver shareholder value.
More about Syncona Shs GBP
Syncona Limited is a prominent life science investor focused on creating, building, and scaling a portfolio of global leaders in the life sciences sector. The company aims to deliver transformational treatments to patients with high unmet needs by partnering with world-class academic founders and experienced management teams. Syncona seeks to maintain a diversified portfolio of 20-25 leading life science businesses, focusing on development stage, modality, and therapeutic areas, while looking to improve patient lives and deliver strong returns to shareholders.
YTD Price Performance: -9.94%
Average Trading Volume: 687,989
Technical Sentiment Consensus Rating: Buy
Learn more about SYNC stock on TipRanks’ Stock Analysis page.
